A Fast-Moving Inherited Macular Dystrophy
An old water pipe that quietly corrodes from the inside eventually forces a rushed repair — a hasty patch soldered on under pressure, prone to leaking again almost as soon as it's fitted. Something comparable happens behind the retina in Sorsby fundus dystrophy: a faulty protein causes Bruch's membrane to thicken in a way it shouldn't, and the retina responds by forcing a network of new blood vessels through that weakened barrier, vessels that are poorly built from the outset and prone to leaking almost immediately. It's this early arrival of abnormal vessel growth — turning up decades before it would in ordinary age-related disease — that earns Sorsby dystrophy its place among the more aggressive conditions covered here.
For a Zambian patient whose central vision collapses over a matter of weeks rather than years, usually somewhere in their thirties or forties, that sheer pace is often the earliest clue pointing toward Sorsby rather than a gentler, more typical dystrophy.
Speed is really the hallmark of this condition — central vision in one eye can genuinely collapse within a matter of weeks, with the second eye usually following within a handful of years. Patients often describe straight lines suddenly appearing bent, or a blurred patch spreading rapidly through the centre of their sight, and some recall a strange difficulty adjusting to dim light that quietly showed up months, or even longer, before anything more obvious.
TIMP3 is the gene at fault here, and its ordinary job is to keep the turnover of tissue around Bruch's membrane properly regulated. Once that job isn't carried out properly, the membrane thickens abnormally, and the retina answers by pushing new vessels through the weakened barrier — vessels that are structurally poor from the start and begin leaking almost as soon as they exist. A single faulty copy, inherited from either parent, is enough on its own to bring the condition on.
A scattering of pale, yellow-white deposits along the retinal vessels is often the first thing to catch an examiner's eye during a routine look at the fundus. From there, imaging turns toward confirming whether active new vessels are present — OCT angiography usually settles it, with fluorescein angiography brought in where a sharper picture is needed, since knowing whether those vessels are leaking changes how urgently we act. A TIMP3 genetic test confirms what's driving things, and given how quickly this condition can move, we treat that test as urgent rather than routine.
Whenever active leaking vessels are found, addressing them takes priority over everything else on the treatment plan. Once the eye has settled and stabilised, eligible patients move into regenerative stem cell therapy aimed at supporting the retina going forward, and because Sorsby has a track record of moving fast, we schedule these patients for review more frequently than we would with a slower-moving dystrophy.
It genuinely can, and that unusual speed is actually one of the details that points us toward Sorsby dystrophy specifically. Almost every other inherited macular condition unfolds over years rather than weeks, which is exactly what makes this pace stand out.
That mix-up does happen, since both conditions can produce new, leaking vessels that look alike on a scan. The dividing line comes down to when it began, whether there's a family history, and a TIMP3 genetic test confirming the cause.
It's certainly something we act on without delay, since untreated leaking vessels can cause further vision loss in a short space of time. Bringing that specific issue under control is always the first priority before anything else.
Not definitely — but the odds are worth taking seriously, since this follows a dominant inheritance pattern and each child of an affected parent carries roughly a fifty percent chance of inheriting the gene. How severely it shows up, if it does, tends to vary from person to person, and genetic testing can give your family a clearer picture.